Clinical Trial Update: Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of Acetyl-L-carnitine in patients with Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED